Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Auspex Diagnostics Logo
Auspex Diagnostics Growth Score
54
CB Rank
705110
Heat Score
38
AI startup that provides treatment personalization using patients' tumor samples
Founded
obfuscation
PrivateSeed Warren, New Jersey, United States1-10 www.auspexdiagnostics.com/
Artificial Intelligence (AI)
Big Data
Biotechnology
Health Care
Health Diagnostics
Machine Learning
Medical
Overview

Auspex Diagnostics
Growth Score
54
Heat Score
38

Growth Score54
-15 pts
in past quarter
Heat Score 38
-19 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Auspex Diagnostics

CB Rank
705110
AI startup that provides treatment personalization using patients' tumor samples
Founded
obfuscation
PrivateSeed Warren, New Jersey, United States1-10 www.auspexdiagnostics.com/
Artificial Intelligence (AI)
Big Data
Biotechnology
Health Care
Health Diagnostics
Machine Learning
Medical

Funding Rounds

Seed
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation

Details

Operating Status Active
Company Type For Profit
Founders  Nien Wei
Contact Email hello@auspexdiagnostics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

Colorectal Cancer Recurrence and Chemotherapy Efficacy Assay
A diagnostic test analyzing tumor gene expression to predict colorectal cancer recurrence risk and chemotherapy effectiveness for stage II and III patients.
Lung Adenocarcinoma Recurrence Prediction Model
A gene expression-based model predicting recurrence risk in stage I lung adenocarcinoma patients after surgical resection.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed

Funding Rounds

Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed
obfuscation
Seed Round - Auspex Diagnostics Logo
Seed Round - Auspex Diagnostics
1
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•Jul 26, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

60

IT Spend

$19.2KThis year, Auspex Diagnostics is projected to spend $19.2K on IT, according to Aberdeen.

Active Website Tech Count

12Auspex Diagnostics is actively using 12 technologies for its website, according to BuiltWith. These include Euro, U.S. Server Location, and  Amazon.
Sub-Organizations
Frequently Asked Questions

Where is Auspex Diagnostics's headquarters? Auspex Diagnostics is located in Warren, New Jersey, United States.Who invested in Auspex Diagnostics? Auspex Diagnostics has 2 investors including TMU BioMed Accelerator and  MassChallenge.When was the last funding round for Auspex Diagnostics? Auspex Diagnostics closed its last funding round on
obfuscation
from a Seed round.Who are Auspex Diagnostics's competitors? Alternatives and possible competitors to Auspex Diagnostics may include Tempus, Artera, and  Guardant Health.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(790e229 1)
|